⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Bromide SCHEMBL6585744 | 0.97 | — | — | |
| SCHEMBL7110786 | 0.73 | FDPS (0.39) | — | |
| SCHEMBL123210 | 0.71 | — | — | |
| SCHEMBL2567591 | 0.69 | FDPS (0.36) | — | |
| SCHEMBL437673 | 0.69 | FDPS (0.36) | — | |
| SCHEMBL20811 | 0.69 | — | — | |
| SCHEMBL11611288 | 0.69 | — | — | |
| SCHEMBL12641026 | 0.69 | FDPS (0.32) | — | |
| Bromide SCHEMBL10706961 | 0.67 | FDPS (0.31) | — | |
| SCHEMBL9983155 | 0.67 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 75 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-117945965-A | Preparation method of tiamulin | 新疆上昵生物科技有限公司 | 2024-04-30 | — | — | CN | claimed |
| CN-117945965-A | Preparation method of tiamulin | 新疆上昵生物科技有限公司 | 2024-04-30 | — | — | CN | disclosed |
| CN-117945965-A | Preparation method of tiamulin | 新疆上昵生物科技有限公司 | 2024-04-30 | — | — | CN | disclosed |
| WO-2023118893-A1 | NOVEL PYRIDOCARBAZOLIUM COMPOUNDS AND MEDICAL USES THEREOF | MYCURAL THERAPEUTICS (SE) | 2023-06-29 | — | — | WO | disclosed |
| US-20230174476-A1 | HIGH PENETRATION PRODRUG COMPOSITIONS OF PROSTAGLANDINS AND RELATED COMPOUNDS | TECHFIELDS PHARMA CO., LTD. (CN) | 2023-06-08 | — | — | US | disclosed |
| US-11555014-B2 | High penetration prodrug compositions of prostaglandins and related compounds | TECHFIELDS PHARMA CO., LTD. (CN) | 2023-01-17 | — | — | US | disclosed |
| CN-115521216-A | Acetylsalicylic acid derivative crystal, and preparation method and application thereof | 浙江越甲药业有限公司 | 2022-12-27 | — | — | CN | disclosed |
| CN-106146326-B | Acetylsalicylic acid derivative crystal and preparation method and application thereof | 浙江越甲药业有限公司 | 2022-10-11 | — | — | CN | disclosed |
| EP-3279182-B1 | ACETYLSALICYLIC ACID DERIVATIVE CRYSTAL AND PREPARATION METHOD AND USE THEREOF | ZHEJIANG YUEJIA PHARMACEUTICALS CO LTD (CN) | 2021-05-26 | — | — | EP | disclosed |
| US-10882817-B2 | Acetylsalicylic acid derivative crystal, its preparation method and use | ZHEJIANG YUEJIA PHARMACEUTICALS CO., LTD (CN) | 2021-01-05 | — | — | US | disclosed |
| WO-1989004305-A1 | QUINOLINE DERIVATIVES AS ANTAGONISTS OF LEUKOTRIENE D4 | RORER INTERNATIONAL (OVERSEAS) INC. (US) | 1989-05-18 | — | — | WO | disclosed |
| EP-0315399-A2 | Quinoline derivatives, their use in the treatment of hypersensitive ailments and a pharmaceutical composition containing the same | RHONE-POULENC RORER INTERNATIONAL (HOLDINGS) INC. (US) | 1989-05-10 | — | — | EP | disclosed |
| EP-0260305-A4 | QUINOLINYL ETHER TETRAZOLE AS AGENT FOR THE TREATMENT OF HYPERSENSITIVE AILMENTS. | RORER INTERNAT OVERSEAS INC (US) | 1988-07-04 | — | — | EP | disclosed |
| EP-0260305-A1 | QUINOLINYL ETHER TETRAZOLE AS AGENT FOR THE TREATMENT OF HYPERSENSITIVE AILMENTS. | RORER INT OVERSEAS (US) | 1988-03-23 | — | — | EP | disclosed |
| WO-1987005510-A1 | QUINOLINYL ETHER OR THIOETHER TETRAZOLES AS AGENTS FOR THE TREATMENT OF HYPERSENSITIVE AILMENTS | RORER INTERNATIONAL (OVERSEAS) INC. (US) | 1987-09-24 | — | — | WO | disclosed |
| US-4415668-A | Cell culture | PRESIDENT AND FELLOWS OF HARVARD COLLEGE (US) | 1983-11-15 | — | — | US | disclosed |
| US-4293654-A | CROSSLINGING DEXTRAN BEADS | MASSACHUSETTS INSTITUTE OF TECHNOLOGY (US) | 1981-10-06 | — | — | US | disclosed |
| US-4189534-A | Cell culture microcarriers | MASSACHUSETTS INSTITUTE OF TECHNOLOGY (US) | 1980-02-19 | — | — | US | disclosed |
| US-4146623-A | SUBSTITUTED FUROIC ACIDS AND ESTERS | RICHARDSON-MERRELL INC. (US) | 1979-03-27 | — | — | US | disclosed |
| US-4110351-A | Hypolipidemic agents RO- or RS- substituted furoic acids, esters and salts | RICHARDSON-MERRELL INC. (US) | 1978-08-29 | — | — | US | disclosed |